DIABETIC RETINOPATHY

This study tested whether levodopa, a medication used for Parkinson's disease, could help protect the retina in people with diabetes before visible eye damage occurs. Researchers gave 230 participants either placebo or different doses of levodopa for six months to find the best d…

This study tested whether taking daily omega-3 supplements could help improve blood vessel health in the eyes of people with early-stage diabetic retinopathy. Researchers enrolled 60 adults with minimal to moderate diabetic eye changes and gave them either omega-3 or a placebo fo…

This study tested whether a medication called aflibercept, injected into the eye, could improve poor blood flow in the retinas of people with diabetic retinopathy. Researchers enrolled 38 adults with moderate diabetic eye damage to see if the treatment could restore circulation a…

This study tested whether a new eye drop called INV-102 could help control diabetic retinopathy, a common cause of vision loss. It involved 19 adults with diabetes who had swelling in the back of the eye. Researchers gave participants the eye drops for 8-12 weeks to see if it red…

This study tested an oral supplement called Nuvastatic to see if it could help control early-stage diabetic retinopathy, a common diabetes complication that damages the retina and can lead to vision loss. It involved 100 adults with type 2 diabetes who had this early eye disease …

This study tested a new automated tool designed to screen for diabetic retinopathy, a serious eye complication of diabetes. The goal was to see if this tool could work well in primary care clinics, making screening easier and more accessible for people with diabetes. Researchers …

This study aimed to develop and test an artificial intelligence (AI) system to better predict the worsening of diabetic retinopathy, a common diabetes complication that can lead to vision loss. Researchers followed over 3,000 diabetic patients for up to three years, collecting ey…

This study tested whether a computer program using artificial intelligence (AI) could accurately detect diabetic eye disease from photos of the back of the eye. It involved 900 people with diabetes and compared the AI's ability to spot problems against the readings of family doct…

This study tested a new, more affordable eye-tracking device called CRYSTALSIGHT that uses artificial intelligence. It was designed to help patients with macular diseases, like age-related macular degeneration, monitor their vision from home. Researchers compared it to a standard…

This Yale University study tested a patient navigator program designed to help people with diabetes get regular eye exams to prevent blindness. The program focused on high-risk patients who hadn't had eye screenings in over a year. Researchers worked with 35 participants to see i…

This study aimed to find out if certain substances in the blood are linked to the severity of diabetic eye damage. Researchers compared blood samples and detailed eye scans from 90 adults, including people with and without diabetes. The goal was to see if measuring these blood ma…

This study aimed to find out if specific patterns seen on standard eye scans could predict how well a patient with diabetic macular edema (a common cause of vision loss in diabetes) would respond to treatment. Researchers observed 32 patients, analyzing their routine eye scan ima…